These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 31073275)

  • 21. PD-1 Status in CD8
    Kansy BA; Concha-Benavente F; Srivastava RM; Jie HB; Shayan G; Lei Y; Moskovitz J; Moy J; Li J; Brandau S; Lang S; Schmitt NC; Freeman GJ; Gooding WE; Clump DA; Ferris RL
    Cancer Res; 2017 Nov; 77(22):6353-6364. PubMed ID: 28904066
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Systemic inflammatory responses and lung injury following hip fracture surgery increases susceptibility to infection in aged rats.
    Zhang H; Sun T; Liu Z; Zhang J; Wang X; Liu J
    Mediators Inflamm; 2013; 2013():536435. PubMed ID: 24163505
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cutting edge: identification of autoreactive CD4+ and CD8+ T cell subsets resistant to PD-1 pathway blockade.
    Pauken KE; Nelson CE; Martinov T; Spanier JA; Heffernan JR; Sahli NL; Quarnstrom CF; Osum KC; Schenkel JM; Jenkins MK; Blazar BR; Vezys V; Fife BT
    J Immunol; 2015 Apr; 194(8):3551-3555. PubMed ID: 25769925
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Blocking Tim-3 or/and PD-1 reverses dysfunction of tumor-infiltrating lymphocytes in HBV-related hepatocellular carcinoma.
    Liu F; Zeng G; Zhou S; He X; Sun N; Zhu X; Hu A
    Bull Cancer; 2018 May; 105(5):493-501. PubMed ID: 29576222
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CD27 Agonism Plus PD-1 Blockade Recapitulates CD4+ T-cell Help in Therapeutic Anticancer Vaccination.
    Ahrends T; Bąbała N; Xiao Y; Yagita H; van Eenennaam H; Borst J
    Cancer Res; 2016 May; 76(10):2921-31. PubMed ID: 27020860
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Therapeutic effect of human ghrelin and growth hormone: Attenuation of immunosuppression in septic aged rats.
    Zhou M; Yang WL; Aziz M; Ma G; Wang P
    Biochim Biophys Acta Mol Basis Dis; 2017 Oct; 1863(10 Pt B):2584-2593. PubMed ID: 28115288
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Farnesyltransferase inhibitor FTI-277 inhibits PD-L1 expression on septic spleen lymphocytes and promotes spleen lymphocyte activation.
    Li W; Tu J; Liu X; Yang W
    Clin Exp Immunol; 2017 Oct; 190(1):8-18. PubMed ID: 28556912
    [TBL] [Abstract][Full Text] [Related]  

  • 28. PD-1:PD-L inhibitory pathway affects both CD4(+) and CD8(+) T cells and is overcome by IL-2.
    Carter L; Fouser LA; Jussif J; Fitz L; Deng B; Wood CR; Collins M; Honjo T; Freeman GJ; Carreno BM
    Eur J Immunol; 2002 Mar; 32(3):634-43. PubMed ID: 11857337
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CD4 T Cell-Derived IFN-γ Plays a Minimal Role in Control of Pulmonary Mycobacterium tuberculosis Infection and Must Be Actively Repressed by PD-1 to Prevent Lethal Disease.
    Sakai S; Kauffman KD; Sallin MA; Sharpe AH; Young HA; Ganusov VV; Barber DL
    PLoS Pathog; 2016 May; 12(5):e1005667. PubMed ID: 27244558
    [TBL] [Abstract][Full Text] [Related]  

  • 30. PD-1 blockade enhances the antitumor efficacy of GM-CSF surface-modified bladder cancer stem cells vaccine.
    Shi X; Zhang X; Li J; Mo L; Zhao H; Zhu Y; Hu Z; Gao J; Tan W
    Int J Cancer; 2018 May; 142(10):2106-2117. PubMed ID: 29243219
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The IFN-γ/PD-L1 axis between T cells and tumor microenvironment: hints for glioma anti-PD-1/PD-L1 therapy.
    Qian J; Wang C; Wang B; Yang J; Wang Y; Luo F; Xu J; Zhao C; Liu R; Chu Y
    J Neuroinflammation; 2018 Oct; 15(1):290. PubMed ID: 30333036
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Abscopal Effects With Hypofractionated Schedules Extending Into the Effector Phase of the Tumor-Specific T-Cell Response.
    Zhang X; Niedermann G
    Int J Radiat Oncol Biol Phys; 2018 May; 101(1):63-73. PubMed ID: 29534901
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro and in vivo effect of PD-1/PD-L1 blockade on microglia/macrophage activation and T cell subset balance in cryptococcal meningitis.
    Che YM; Zhang Y; Li M; Li XP; Zhang LL
    J Cell Biochem; 2018 Apr; 119(4):3044-3057. PubMed ID: 29058791
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunotherapy With Antiprogrammed Cell Death 1 Antibody Improves Outcome in a Mouse Model of Spinal Cord Injury Followed by Staphylococcus aureus Pneumonia.
    Ruggeri T; Jacqueline C; Ambrosi X; Broquet A; Desfrançois J; Roquilly A; Altare F; Asehnoune K
    Crit Care Med; 2019 Jan; 47(1):e28-e35. PubMed ID: 30303841
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adenosine Receptor 2A Blockade Increases the Efficacy of Anti-PD-1 through Enhanced Antitumor T-cell Responses.
    Beavis PA; Milenkovski N; Henderson MA; John LB; Allard B; Loi S; Kershaw MH; Stagg J; Darcy PK
    Cancer Immunol Res; 2015 May; 3(5):506-17. PubMed ID: 25672397
    [TBL] [Abstract][Full Text] [Related]  

  • 36. PD-1 expression by canine T cells and functional effects of PD-1 blockade.
    Coy J; Caldwell A; Chow L; Guth A; Dow S
    Vet Comp Oncol; 2017 Dec; 15(4):1487-1502. PubMed ID: 28120417
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Blockade of B7-H1 on macrophages suppresses CD4+ T cell proliferation by augmenting IFN-gamma-induced nitric oxide production.
    Yamazaki T; Akiba H; Koyanagi A; Azuma M; Yagita H; Okumura K
    J Immunol; 2005 Aug; 175(3):1586-92. PubMed ID: 16034097
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MiR155 sensitized B-lymphoma cells to anti-PD-L1 antibody via PD-1/PD-L1-mediated lymphoma cell interaction with CD8+T cells.
    Zheng Z; Sun R; Zhao HJ; Fu D; Zhong HJ; Weng XQ; Qu B; Zhao Y; Wang L; Zhao WL
    Mol Cancer; 2019 Mar; 18(1):54. PubMed ID: 30925928
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibitory signals mediated by programmed death-1 are involved with T-cell function in chronic periodontitis.
    Figueira EA; de Rezende ML; Torres SA; Garlet GP; Lara VS; Santos CF; Avila-Campos MJ; da Silva JS; Campanelli AP
    J Periodontol; 2009 Nov; 80(11):1833-44. PubMed ID: 19905953
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment with Interleukin-7 Restores Host Defense against Pneumocystis in CD4+ T-Lymphocyte-Depleted Mice.
    Ruan S; Samuelson DR; Assouline B; Morre M; Shellito JE
    Infect Immun; 2016 Jan; 84(1):108-19. PubMed ID: 26483405
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.